Cargando…
Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935161/ http://dx.doi.org/10.1016/j.dld.2022.01.005 |
| _version_ | 1784671987177619456 |
|---|---|
| author | Iavarone, M. Tosetti, G. Facchetti, F. Topa, M. Lombardi, A. D'Ambrosio, R. Degasperi, E. Loglio, A. Oggioni, C. Bandera, A. Gori, A. Ceriotti, F. Scudeller, L. Bertoletti, A. Lampertico, P. |
| author_facet | Iavarone, M. Tosetti, G. Facchetti, F. Topa, M. Lombardi, A. D'Ambrosio, R. Degasperi, E. Loglio, A. Oggioni, C. Bandera, A. Gori, A. Ceriotti, F. Scudeller, L. Bertoletti, A. Lampertico, P. |
| author_sort | Iavarone, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8935161 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89351612022-03-21 Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study Iavarone, M. Tosetti, G. Facchetti, F. Topa, M. Lombardi, A. D'Ambrosio, R. Degasperi, E. Loglio, A. Oggioni, C. Bandera, A. Gori, A. Ceriotti, F. Scudeller, L. Bertoletti, A. Lampertico, P. Dig Liver Dis OC-1 Published by Elsevier Ltd. 2022-03 2022-03-21 /pmc/articles/PMC8935161/ http://dx.doi.org/10.1016/j.dld.2022.01.005 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | OC-1 Iavarone, M. Tosetti, G. Facchetti, F. Topa, M. Lombardi, A. D'Ambrosio, R. Degasperi, E. Loglio, A. Oggioni, C. Bandera, A. Gori, A. Ceriotti, F. Scudeller, L. Bertoletti, A. Lampertico, P. Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title | Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_full | Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_fullStr | Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_full_unstemmed | Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_short | Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_sort | humoral, cellular, clinical responses and safety of two doses of sars-cov-2 messenger rna vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| topic | OC-1 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935161/ http://dx.doi.org/10.1016/j.dld.2022.01.005 |
| work_keys_str_mv | AT iavaronem humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT tosettig humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT facchettif humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT topam humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT lombardia humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT dambrosior humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT degasperie humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT loglioa humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT oggionic humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT banderaa humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT goria humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT ceriottif humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT scudellerl humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT bertolettia humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT lamperticop humoralcellularclinicalresponsesandsafetyoftwodosesofsarscov2messengerrnavaccineinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy |